Page last updated: 2024-08-18

acrolein and Hypertension

acrolein has been researched along with Hypertension in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (22.22)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (11.11)	29.6817
2010's	3 (33.33)	24.3611
2020's	3 (33.33)	2.80

Authors

Authors	Studies
Bhatnagar, A; DeJarnett, N; Hall, ME; Keith, RJ; Konkle, SL; McGraw, KE; Oshunbade, A; Rai, SN; Riggs, DW; Shimbo, D; Xie, Z	1
Barre, DE; Mizier-Barre, KA	1
Baba, SP; Bhatnagar, A; Hoetker, DJ; Li, X; O'Toole, TE; Riggs, DW	1
Costa, DL; Farraj, AK; Griggs, J; Haykal-Coates, N; Hazari, MS; Ledbetter, A; Winsett, DW	1
Carll, AP; Cascio, WE; Costa, DL; Farraj, AK; Haykal-Coates, N; Hazari, MS; Ledbetter, AD; Perez, CM; Winsett, DW	1
Badawy, D; El-Bassossy, HM; Fahmy, A	1
Abe, M; Hisano, S; Horiuchi, S; Iwasaki, H; Nangaku, M; Sakata, N; Uesugi, N	1
Haber, SB; Kutzman, RS; Wehner, RW	1
Egle, JL; Green, MA	1

Reviews

1 review(s) available for acrolein and Hypertension

Article	Year
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus. Endocrine regulations, 2020, Apr-01, Volume: 54, Issue:2 Topics: Acrolein; Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Inflammation; Obesity, Abdominal; Polypharmacy	2020

Article

Year

The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus.

Endocrine regulations, 2020, Apr-01, Volume: 54, Issue:2

Topics: Acrolein; Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Inflammation; Obesity, Abdominal; Polypharmacy

2020

Other Studies

8 other study(ies) available for acrolein and Hypertension

Article	Year
Exposure to Volatile Organic Compounds Is Associated with Hypertension in Black Adults: The Jackson Heart Study. Environmental research, 2023, 04-15, Volume: 223 Topics: Acrolein; Adult; Bayes Theorem; Humans; Hypertension; Longitudinal Studies; Male; Styrenes; Volatile Organic Compounds	2023
Urinary Levels of the Acrolein Conjugates of Carnosine Are Associated with Cardiovascular Disease Risk. International journal of molecular sciences, 2021, Jan-30, Volume: 22, Issue:3 Topics: Acrolein; Adult; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Carnosine; Cohort Studies; Diabetes Mellitus; Female; Heart Failure; Humans; Hyperlipidemias; Hypertension; Linear Models; Lipoproteins, HDL; Male; Risk Assessment; Risk Factors	2021
A single exposure to acrolein desensitizes baroreflex responsiveness and increases cardiac arrhythmias in normotensive and hypertensive rats. Cardiovascular toxicology, 2014, Volume: 14, Issue:1 Topics: Acrolein; Air Pollutants; Animals; Arrhythmias, Cardiac; Baroreflex; Blood Pressure; Blood Pressure Determination; Disease Models, Animal; Electrocardiography, Ambulatory; Heart Rate; Hypertension; Male; Plethysmography, Whole Body; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Respiration; Risk Assessment; Telemetry; Time Factors	2014
Acrolein inhalation alters arterial blood gases and triggers carotid body-mediated cardiovascular responses in hypertensive rats. Inhalation toxicology, 2015, Volume: 27, Issue:1 Topics: Acrolein; Alkynes; Animals; Blood Gas Analysis; Carotid Body; Cystathionine gamma-Lyase; Glycine; Heart Rate; Hypertension; Male; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Pressure	2015
Cinnamaldehyde protects from the hypertension associated with diabetes. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2011, Volume: 49, Issue:11 Topics: Acetylcholinesterase; Acrolein; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium; Diabetes Mellitus, Experimental; Hypertension; Hypoglycemic Agents; Insulin Resistance; Male; Nitric Oxide; Pioglitazone; Potassium Chloride; Rats; Rats, Wistar; Thiazolidinediones; Vasoconstriction	2011
Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 44, Issue:2 Topics: Acrolein; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Complement Activation; Complement Membrane Attack Complex; Diabetic Nephropathies; Female; Glomerulosclerosis, Focal Segmental; Glycation End Products, Advanced; Humans; Hypertension; Kidney; Kidney Glomerulus; Lysine; Male; Middle Aged; Models, Biological; Nephrosclerosis; Oxidation-Reduction; Tunica Media	2004
Selected responses of hypertension-sensitive and resistant rats to inhaled acrolein. Toxicology, 1984, May-01, Volume: 31, Issue:1 Topics: Acrolein; Aldehydes; Animals; Behavior, Animal; Blood Chemical Analysis; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Female; Hypertension; Lung; Organ Size; Proteins; Rats	1984
The effects of acetaldehyde and acrolein on blood pressure in guanethidine-pretreated hypertensive rats. Toxicology and applied pharmacology, 1983, Jun-15, Volume: 69, Issue:1 Topics: Acetaldehyde; Acrolein; Aldehydes; Animals; Blood Pressure; Disease Models, Animal; Drug Interactions; Ethanol; Guanethidine; Hypertension; Nicotiana; Plants, Toxic; Rats; Rats, Inbred Strains; Smoke	1983